Table 2.
Training set results combined FOXE1 and SYNE1
| SYNE1 and FOXE1 | ||
|---|---|---|
| Patient group | Positive | Sensitivity |
| Stage I | 18/43 | 42% |
| Stage II | 25/44 | 57% |
| Stage III | 27/46 | 59% |
| Stage IV | 17/21 | 81% |
| Case total | 87/154 | 56% |
| Specificity | ||
| Control | 46/444 | 90% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.